tiprankstipranks
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market
JSPR
Jasper Therapeutics
RESEARCH TOOLSreports

Jasper Therapeutics (JSPR) Income Statement

1,056 Followers

Jasper Therapeutics Income Statement

Last quarter (Q4 2025), Jasper Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Jasper Therapeutics's net income was $-9.10M. See Jasper Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.06M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 83.88M$ 76.24M$ 68.86M$ 51.20M$ 36.83M
Depreciation and Amortization
$ 1.06M$ 1.37M$ 1.11M$ 975.00K$ 377.00K
EBITDA
$ -82.83M$ -74.87M$ -67.75M$ -50.22M$ -36.46M
Operating Income
$ -80.52M$ -76.24M$ -68.86M$ -51.20M$ -36.83M
Other Income/Expenses
$ 4.72M$ 4.97M$ 4.40M$ 13.51M$ 6.20M
Pretax Income
$ -75.80M$ -71.27M$ -64.47M$ -37.69M$ -30.64M
Net Income
$ -75.80M$ -71.27M$ -64.47M$ -37.69M$ -30.64M
Per Share Metrics
Basic EPS
$ -3.95$ -4.89$ -6.18$ -10.33$ -26.89
Diluted EPS
$ -3.95$ -4.89$ -6.18$ -10.33$ -26.89
Weighted Average Shares Outstanding
 19.17M 14.58M 10.44M 3.65M 1.14M
Weighted Average Shares Outstanding (Diluted)
 15.33M 14.58M 10.44M 3.65M 1.14M
Currency in USD

Jasper Therapeutics Earnings and Revenue History